Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Hochschild tanks on big cut to Mara Rosa gold output forecast

(Sharecast News) - Shares in Hochschild Mining tanked by 20% on Tuesday after the company said it expected a "significant reduction" to output guidance at its Mara Rosa gold mine in Brazil due to a processing shutdown caused by heavier-than-usual seasonal rainfall over the past few months and "contractor performance issues". The miner on Tuesday said a review of activities at the mine would lead to a six-week processing plant suspension after adverse conditions limited access to ore, particularly higher-grade zones within the pit.

"As a result, efforts to recover from delays in mine waste removal carried over from the previous year have been further prolonged," the company said in a statement. Mining operations will continue as planned, it added.

At the start of the year, the Mara Rosa mine was expected to produce between 94,000 and 104,000 ounces of gold in 2025 and as at the end of May, the mine had produced just over 25,000 ounces.

"The measures being taken are expected to result in a significant reduction to that guidance and this will have a corresponding impact on the operation's costs," Hochschild said.

Reporting for Sharecast.com by Frank Prenesti

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.